Literature DB >> 26049017

Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat.

Aline Pic-Taylor1, Luciana Gueiros da Motta2, Juliana Alves de Morais1, Willian Melo Junior1, Alana de Fátima Andrade Santos2, Leandro Ambrósio Campos3, Marcia Renata Mortari3, Marcus Vinicius von Zuben4, Eloisa Dutra Caldas5.   

Abstract

Ayahuasca, a psychoactive beverage used by indigenous and religious groups, is generally prepared by the coction of Psychotria viridis and Banisteriopsis caapi plants containing N,N-dimethyltryptamine (DMT) and β-carboline alkaloids, respectively. To investigate the acute toxicity of ayahuasca, the infusion was administered by gavage to female Wistar rats at doses of 30X and 50X the dose taken during a religious ritual, and the animals observed for 14 days. Behavioural functions were investigated one hour after dosing at 15X and 30X using the open field, elevated plus maze, and forced swimming tests. Neuronal activation (c-fos marked neurons) and toxicity (Fluoro-Jade B and Nissl/Cresyl staining) were investigated in the dorsal raphe nuclei (DRN), amygdaloid nucleus, and hippocampal formation brain areas of rats treated with a 30X ayahuasca dose. The actual lethal oral dose in female Wistar rats could not be determined in this study, but was shown to be higher than the 50X (which corresponds to 15.1mg/kg bw DMT). The ayahuasca and fluoxetine treated groups showed a significant decrease in locomotion in the open field and elevated plus-maze tests compared to controls. In the forced swimming test, ayahuasca treated animals swam more than controls, a behaviour that was not significant in the fluoxetine group. Treated animals showed higher neuronal activation in all brain areas involved in serotoninergic neurotransmission. Although this led to some brain injury, no permanent damage was detected. These results suggest that ayahuasca has antidepressant properties in Wistar female at high doses, an effect that should be further investigated.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute doses; Ayahuasca; Behavioural tests; Neurotoxicity; Rat

Mesh:

Substances:

Year:  2015        PMID: 26049017     DOI: 10.1016/j.beproc.2015.05.004

Source DB:  PubMed          Journal:  Behav Processes        ISSN: 0376-6357            Impact factor:   1.777


  17 in total

Review 1.  Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.

Authors:  Rafael G Dos Santos; Flávia L Osório; José Alexandre S Crippa; Jordi Riba; Antônio W Zuardi; Jaime E C Hallak
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-18

2.  Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression.

Authors:  Lindsay P Cameron; Charlie J Benson; Lee E Dunlap; David E Olson
Journal:  ACS Chem Neurosci       Date:  2018-04-24       Impact factor: 4.418

3.  Evidence on the impairing effects of Ayahuasca on fear memory reconsolidation.

Authors:  Daiane Momo Daneluz; Jeferson Machado Batista Sohn; Gabriela O Silveira; Maurício Yonamine; Cristina Aparecida Stern
Journal:  Psychopharmacology (Berl)       Date:  2022-09-07       Impact factor: 4.415

Review 4.  Neuropharmacology of N,N-dimethyltryptamine.

Authors:  Theresa M Carbonaro; Michael B Gatch
Journal:  Brain Res Bull       Date:  2016-04-25       Impact factor: 4.077

5.  Rats overexpressing the dopamine transporter display behavioral and neurobiological abnormalities with relevance to repetitive disorders.

Authors:  Ravit Hadar; Henriette Edemann-Callesen; Claudia Reinel; Franziska Wieske; Mareike Voget; Elena Popova; Reinhard Sohr; Yosef Avchalumov; Josef Priller; Christoph van Riesen; Imke Puls; Michael Bader; Christine Winter
Journal:  Sci Rep       Date:  2016-12-15       Impact factor: 4.379

6.  Behavioral Changes Over Time Following Ayahuasca Exposure in Zebrafish.

Authors:  Robson Savoldi; Daniel Polari; Jaquelinne Pinheiro-da-Silva; Priscila F Silva; Bruno Lobao-Soares; Mauricio Yonamine; Fulvio A M Freire; Ana C Luchiari
Journal:  Front Behav Neurosci       Date:  2017-07-28       Impact factor: 3.558

7.  The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro.

Authors:  Jose A Morales-García; Mario de la Fuente Revenga; Sandra Alonso-Gil; María Isabel Rodríguez-Franco; Amanda Feilding; Ana Perez-Castillo; Jordi Riba
Journal:  Sci Rep       Date:  2017-07-13       Impact factor: 4.379

8.  An ontogenic study of the behavioral effects of chronic intermittent exposure to ayahuasca in mice.

Authors:  N F Correa-Netto; M Y Masukawa; F Nishide; G S Galfano; F Tamura; M K Shimizo; M P Marcato; J G Santos; A Linardi
Journal:  Braz J Med Biol Res       Date:  2017-06-05       Impact factor: 2.590

Review 9.  N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function.

Authors:  Steven A Barker
Journal:  Front Neurosci       Date:  2018-08-06       Impact factor: 4.677

10.  Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls.

Authors:  Ana C de Menezes Galvão; Raíssa N de Almeida; Erick A Dos Santos Silva; Fúlvio A M Freire; Fernanda Palhano-Fontes; Heloisa Onias; Emerson Arcoverde; João P Maia-de-Oliveira; Dráulio B de Araújo; Bruno Lobão-Soares; Nicole L Galvão-Coelho
Journal:  Front Psychiatry       Date:  2018-05-08       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.